What are the skin manifestations of Hyper-IgD (Hyperimmunoglobulinemia D) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Skin Manifestations of Hyper-IgD Syndrome

Skin lesions occur in approximately 79% of patients with Hyper-IgD syndrome during febrile attacks, with erythematous macules being the most common presentation, followed by erythematous papules, urticarial lesions, and erythematous nodules. 1

Primary Cutaneous Manifestations

The skin lesions in Hyper-IgD syndrome appear during febrile episodes and include:

  • Erythematous macules are the most frequent cutaneous finding, occurring in approximately 43% of patients with skin involvement 1
  • Erythematous papules present in approximately 34% of patients with cutaneous manifestations 1
  • Urticarial lesions develop in approximately 26% of patients with skin involvement 1
  • Erythematous nodules appear in approximately 20% of patients with cutaneous disease 1

Distribution and Timing

  • Skin lesions typically appear during febrile attacks and are considered a true manifestation of the disease rather than an incidental finding 1
  • The cutaneous manifestations occur alongside other systemic symptoms including fever, abdominal distress, joint involvement, headache, and lymphadenopathy 1, 2
  • Lesions may occasionally present on the distal parts of upper and lower extremities 3

Histopathologic Features

The histologic findings in Hyper-IgD syndrome are variable and often nonspecific:

  • Mild vasculitis features are the most common histopathologic finding in skin biopsy specimens 1
  • Leukocytoclastic vasculitis pattern can be observed, particularly in lesions on the extremities 3
  • Nonspecific inflammatory changes are noted in approximately 50% of biopsy specimens 1
  • Sweet-like features (neutrophilic dermatosis pattern) occur in approximately 20% of cases 1
  • Cellulitis-like findings and deep vasculitis characteristics are less common presentations 1

Immunopathologic Mechanism

  • IgD immune complex deposition has been demonstrated in skin lesions, with perivascular deposits of IgD and C3 found on immunofluorescence examination of early lesional skin 3
  • Circulating IgD immune complexes can be detected both during and between clinical attacks, suggesting an IgD immune complex-mediated pathogenesis for the skin lesions 3
  • The cytokine network is activated during attacks, with elevated IL-6, TNF-alpha, and acute-phase proteins (CRP and PLA2) that may contribute to the inflammatory skin manifestations 4

Clinical Context and Differential Diagnosis

When evaluating suspected Hyper-IgD syndrome with skin manifestations:

  • Confirm elevated serum IgD (>100 U/mL) as this is a defining feature of the syndrome 2, 5
  • Document the periodic nature of symptoms, as attacks recur throughout life although frequency and severity may diminish with age 2, 5
  • Distinguish from other periodic fever syndromes including Familial Mediterranean Fever, TRAPS, CINCA syndrome, and FAPA syndrome, which may share some cutaneous features but have normal serum IgD levels 2, 5
  • Consider skin biopsy when the diagnosis is uncertain, though histopathologic findings are often nonspecific and multiple biopsies may be needed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.